smallmolecul fragment bind biomacromolecul start point develop drug often difficult detect due low affine present strategy identify proteinbind potent induce targetguid format coal bound irrevers enzyme inhibitor nucleophil react revert biselectrophil warhead thereby post second electrophil close profit active site viral proteam result coal reactive concept implement coxsacki virus b c pharmacology target enterovir infect use aldehydeepoxid biselectrophil fragment combine valid measure protein inactive rate detect modify mass spectrometry structure one enzymeinhibitor complex determine gray crystallography present active assay provide potent nonpeptid broadspectrum proteam 